on 23 Mar 2022
Last Applicant/ Owned by
GLOBAL BLOOD THERAPEUTICS INC.
181 Oyster Point BoulevardSouth San Francisco CA 94080
US
Serial Number
2002125 filed on 16th Oct 2019
Registration Number
TMA1123920 registered on 23rd Mar 2022
Registration expiry Date
16th Oct 2029Trademark usage description
pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of Read More11
11
2002125
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 27 on 16th Apr 2021 | Approval Notice Sent |
Submitted for opposition 22 on 12th Apr 2021 | Search Recorded |
Submitted for opposition 135 on 3rd Mar 2021 | Amendment to Application |
Submitted for opposition 256 on 19th Oct 2020 | Notification of Possible Opposition Sent |
Submitted for opposition 236 on 10th Jun 2020 | Partial Withdrawal - Madrid Protocol |
Submitted for opposition 257 on 19th Dec 2019 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 18th Dec 2019 | Created |
Submitted for opposition 31 on 18th Dec 2019 | Formalized |
Submitted for opposition 30 on 16th Oct 2019 | Filed |
Submitted for opposition 228 on 16th Oct 2019 | International Registration |